A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependence
PG Barnett, JH Rodgers, DA Bloch - Addiction, 2001 - Wiley Online Library
Background. The unique pharmacological properties of buprenorphine may make it a useful
maintenance therapy for opiate addiction. This meta‐analysis considers the effectiveness of …
maintenance therapy for opiate addiction. This meta‐analysis considers the effectiveness of …
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1
Opioids are very effective analgesics, but they are also highly addictive. Methadone is used
to treat opioid dependence (OD), acting as a selective agonist at the μ-opioid receptor …
to treat opioid dependence (OD), acting as a selective agonist at the μ-opioid receptor …
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with …
Objective: The objective of this secondary analysis was to explore differences in baseline
clinical characteristics and opioid replacement therapy treatment outcomes by type (heroin …
clinical characteristics and opioid replacement therapy treatment outcomes by type (heroin …
Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis
C Nordt, R Stohler - The Lancet, 2006 - thelancet.com
Background Switzerland has been criticised for its liberal drug policy, which could attract
new users and lengthen periods of heroin addiction. We sought to estimate incidence trends …
new users and lengthen periods of heroin addiction. We sought to estimate incidence trends …
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome
G Gerra, F Borella, A Zaimovic, G Moi… - Drug and alcohol …, 2004 - Elsevier
The present study compared in a clinical non-experimental setting the efficacy of
buprenorphine (BUP) and methadone (METH) in the treatment of opioid dependence: all the …
buprenorphine (BUP) and methadone (METH) in the treatment of opioid dependence: all the …
Predictors of patient retention in methadone maintenance treatment.
SL Proctor, AL Copeland, AM Kopak… - Psychology of …, 2015 - psycnet.apa.org
This study sought to determine whether select pretreatment demographic and in-treatment
clinical variables predict premature treatment discharge at 6 and 12 months among patients …
clinical variables predict premature treatment discharge at 6 and 12 months among patients …
Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine
PK Heikman, LH Muhonen, IA Ojanperä - BMC psychiatry, 2017 - Springer
Background Polydrug abuse is a known problem among opioid-dependent patients
receiving opioid maintenance treatment (OMT). However, improved laboratory diagnostics is …
receiving opioid maintenance treatment (OMT). However, improved laboratory diagnostics is …
Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance
KL Preston, A Umbricht… - Archives of General …, 2000 - jamanetwork.com
Background Although methadone maintenance is an effective therapy for heroin
dependence, some patients continue to use heroin and may benefit from therapeutic …
dependence, some patients continue to use heroin and may benefit from therapeutic …
Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel
E Peles, S Schreiber, M Adelson - Drug and alcohol dependence, 2006 - Elsevier
The aims were to identify predictors of treatment retention in an Israeli methadone
maintenance treatment (MMT) clinic, and to compare the findings to other international …
maintenance treatment (MMT) clinic, and to compare the findings to other international …
Medication development for addictive disorders: the state of the science
FJ Vocci, J Acri, A Elkashef - American Journal of Psychiatry, 2005 - Am Psychiatric Assoc
In 1989, the National Institute on Drug Abuse (NIDA) established its Medications
Development Program. This program has concentrated on developing pharmacotherapies …
Development Program. This program has concentrated on developing pharmacotherapies …